Wikipedia

Carrie Bearden

Carrie Elyse Bearden is an American psychologist and academic. She is a professor at the David Geffen School of Medicine, University of California, Los Angeles,[1] and Director of the UCLA Center for the Assessment and Prevention of Prodromal States, a clinical research program for youth at high risk for psychotic disorders.[2] She is most known for her research taking a ‘genetics first’ approach to study brain mechanisms underlying the development of serious mental illness. Her work has identified biological convergence between genetically and clinically defined high-risk populations.[3]

Carrie Elyse Bearden
NationalityAmerican
Occupation(s)Psychologist and academic
Awards33rd H.W. Magoun Annual Distinguished Lectureship, Brain Research Institute, UCLA (2022)
Fellow of the Association for Psychological Science (2019)
Joel Elkes Research Award, American College of Neuropsychopharmacology (2017)
A.E. Bennett Neuropsychiatric Research Award for Clinical Science, Society of Biological Psychiatry (2002)
Academic background
Alma materUC Berkeley
University of Pennsylvania
ThesisThe Neurocognitive Phenotype of 22q11.2 Deletion Syndrome
Doctoral advisorTyrone D. Cannon
Academic work
InstitutionsUniversity of California, Los Angeles

Early life and education

edit

Bearden was born in Houston, Texas and grew up in Hawaii Kai, Hawaii. She moved to Milpitas, California at age 13 and attended Milpitas High School.[4] She then earned a Bachelor of Arts degree in Psychology from the University of California at Berkeley in 1993, following which she joined the Kewalo Basin Marine Mammal Laboratory at the University of Hawaii as a Research Intern, where she studied dolphin communication. She then became a Research Associate at the Western Psychiatric Institute and Clinic in Pittsburgh, working for the MacArthur Network on Development and Psychopathology. She then obtained a PhD in Clinical Psychology from the University of Pennsylvania.[1] She completed her postdoctoral fellowship in pediatric cognitive neuroscience at the University of Pennsylvania and Children's Hospital of Philadelphia from 2001 to 2002.

Career

edit

In 2003, Bearden joined the faculty at the University of California, Los Angeles, where she is currently a professor in the Department of Psychiatry and Biobehavioral Sciences,[1] the Semel Institute of Neuroscience and Human Behavior, and Brain Research Institute, and holds a joint appointment in the UCLA Department of Psychology.[5]

Bearden serves as the Director of the UCLA Center for the Assessment and Prevention of Prodromal States[2] and the Adolescent Serious Mental Illness Psychology Internship and Externship Tracks, and Vice Chair of the Academic Appointments and Advancement Committee for the UCLA Department of Psychiatry and Biobehavioral Sciences since 2022. She currently chairs the DSM-V Serious Mental Disorders Committee.

Research

edit

Bearden has authored over 300 publications in peer-reviewed scientific journals and book chapters, spanning the areas of developmental psychopathology, brain imaging, biomarkers of psychosis risk and neurogenetics.[6]

Rare neurogenetic disorders

edit

Bearden has conducted research on copy number variants (CNVs) that are highly penetrant for psychiatric conditions, particularly the 22q11.2 deletion, using it as a model to investigate susceptibility to developmental neuropsychiatric disorders. Her early research characterized the neuropsychiatric manifestations observed in individuals with 22q11.2 deletion syndrome (22q11DS) and highlighted the potential of animal models to replicate specific aspects of this syndrome, providing a platform for future translational research and identification of drug targets.[7] Conducting cortical mapping studies of large samples of individuals with 22q11DS, she demonstrated that deletion size has a considerable impact on brain structure in this disorder. Additionally, her work highlighted a marked convergence of affected brain regions between psychosis in 22q11DS and idiopathic schizophrenia.[8] Her lab also found evidence that duplications at the 22q11.2 locus – a CNV that is putatively protective against schizophrenia- are associated with global opposing effects on brain structure.[9]

Biomarkers for psychosis

edit

Bearden's research in the identification of biomarkers for psychosis in at-risk youth has contributed to the development of early intervention strategies and personalized treatment plans for individuals at risk of developing psychotic disorders. Through epidemiological studies, her work revealed that abnormalities in neuromotor function, language, and cognition during early development can predict schizophrenia later in life.[10] Based on these early findings she has conducted prospective longitudinal studies both independently and collectively as part of the North American Prodromal Longitudinal Study (NAPLS) multisite consortium on youth at clinical high risk (CHR) for psychosis, identifying brain-based biomarkers that predict outcomes in at-risk youth both at baseline and progressively over time.[11][12][13] She co-leads the Psychosis-Risk Outcomes Network (ProNET) global multisite study of youth at CHR for psychosis, part of the Accelerating Medicines Partnership Schizophrenia (AMP-SCZ).[14]

Awards and honors

edit
  • 2002 – A.E. Bennett Neuropsychiatric Research Award for Clinical Science, Society of Biological Psychiatry
  • 2003, 2006 – Young Investigator Award, National Alliance for Research on Schizophrenia and Affective Disorders
  • 2006 – Samuel Gershon Junior Investigator Award, International Society for Bipolar Disorders[15]
  • 2012 – UCLA Semel Institute Teaching Award, Outstanding Research Mentor Award
  • 2015 – Joanne and George Miller Family Endowed Term chair, UCLA Brain Research Institute[16]
  • 2016 – Fellow, American College of Neuropsychopharmacology
  • 2017 – Joel Elkes Research Award, American College of Neuropsychopharmacology[3]
  • 2019 – Fellow of the Association for Psychological Science[17]
  • 2020 – Clarivate Analytics, most highly cited researchers (Top 1%, Jan 2010– Dec 2020)[18]
  • 2022 – George M Thompson Award for Distinguished Service, SOBP Women's Leadership Group (team award)[19]
  • 2022 – 33rd H.W. Magoun Annual Distinguished Lectureship, Brain Research Institute[20]

Selected articles

edit
  • Sanders, S. J., Sahin, M., Hostyk, J., Thurm, A., Jacquemont, S., Avillach, P., ... & Bearden, C. E. (2019). A framework for the investigation of rare genetic disorders in neuropsychiatry. Nature medicine, 25(10), 1477–1487.
  • Ching, C. R., Gutman, B. A., Sun, D., Villalon Reina, J., Ragothaman, A., Isaev, D., ... & Bearden, C. E. (2020). Mapping subcortical brain alterations in 22q11. 2 deletion syndrome: Effects of deletion size and convergence with idiopathic neuropsychiatric illness. American Journal of Psychiatry, 177(7), 589–600.
  • Davies, R. W., Fiksinski, A. M., Breetvelt, E. J., Williams, N. M., Hooper, S. R., Monfeuga, T., ... & Vorstman, J. A. (2020). Using common genetic variation to examine phenotypic expression and risk prediction in 22q11. 2 deletion syndrome. Nature medicine, 26(12), 1912–1918.
  • Sun, D., Ching, C. R., Lin, A., Forsyth, J. K., Kushan, L., Vajdi, A., ... & Bearden, C. E. (2020). Large-scale mapping of cortical alterations in 22q11. 2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size. Molecular psychiatry, 25(8), 1822–1834.
  • Forsyth, J. K., Nachun, D., Gandal, M. J., Geschwind, D. H., Anderson, A. E., Coppola, G., & Bearden, C. E. (2020). Synaptic and gene regulatory mechanisms in schizophrenia, autism, and 22q11. 2 copy number variant–mediated risk for neuropsychiatric disorders. Biological psychiatry, 87(2), 150–163.
  • Moreau, C. A., Ching, C. R., Kumar, K., Jacquemont, S., & Bearden, C. E. (2021). Structural and functional brain alterations revealed by neuroimaging in CNV carriers. Current opinion in genetics & development, 68, 88–98.

References

edit
  1. ^ a b c "UCLA Brain Research Institute (BRI)".
  2. ^ a b "Our Team". UCLA CAPPS.
  3. ^ a b "Joel Elkes Research Previous Award Winners". ACNP.
  4. ^ "Milpitas High School". mhs.musd.org.
  5. ^ "Carrie Bearden • UCLA Department of Psychology". June 7, 2021.
  6. ^ "Carrie BEARDEN | Professor | Ph.D. | University of California, Los Angeles, CA | UCLA | Semel Institute for Neuroscience and Human Behavior | Research profile".
  7. ^ Jonas, Rachel K.; Montojo, Caroline A.; Bearden, Carrie E. (March 1, 2014). "The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan". Biological Psychiatry. 75 (5): 351–360. doi:10.1016/j.biopsych.2013.07.019. PMC 3875621. PMID 23992925.
  8. ^ D, Sun; Crk, Ching; A, Lin; Jk, Forsyth; L, Kushan; A, Vajdi; M, Jalbrzikowski; L, Hansen; Je, Villalon-Reina; X, Qu; Rk, Jonas; T, van Amelsvoort; G, Bakker; Wr, Kates; Km, Antshel; W, Fremont; Le, Campbell; Kl, McCabe; E, Daly; M, Gudbrandsen; Cm, Murphy; D, Murphy; M, Craig; J, Vorstman; A, Fiksinski; S, Koops; K, Ruparel; Dr, Roalf; Re, Gur; Je, Schmitt; Tj, Simon; Nj, Goodrich-Hunsaker; Ca, Durdle; As, Bassett; Ewc, Chow; Nj, Butcher; F, Vila-Rodriguez; J, Doherty; A, Cunningham; Mbm, van den Bree; Dej, Linden; H, Moss; Mj, Owen; Kc, Murphy; Dm, McDonald-McGinn; B, Emanuel; Tgm, van Erp; Ja, Turner; Pm, Thompson; Ce, Bearden (August 4, 2020). "Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size". Molecular Psychiatry. 25 (8): 1822–1834. doi:10.1038/s41380-018-0078-5. PMC 6292748. PMID 29895892.
  9. ^ Lin, Amy; Vajdi, Ariana; Kushan-Wells, Leila; Helleman, Gerhard; Hansen, Laura Pacheco; Jonas, Rachel K.; Jalbrzikowski, Maria; Kingsbury, Lyle; Raznahan, Armin; Bearden, Carrie E. (August 1, 2020). "Reciprocal Copy Number Variations at 22q11.2 Produce Distinct and Convergent Neurobehavioral Impairments Relevant for Schizophrenia and Autism Spectrum Disorder". Biological Psychiatry. 88 (3): 260–272. doi:10.1016/j.biopsych.2019.12.028. PMC 7354903. PMID 32143830.
  10. ^ Bearden, C. E.; Rosso, I. M.; Hollister, J. M.; Sanchez, L. E.; Hadley, T.; Cannon, T. D. (May 4, 2000). "A prospective cohort study of childhood behavioral deviance and language abnormalities as predictors of adult schizophrenia". Schizophrenia Bulletin. 26 (2): 395–410. doi:10.1093/oxfordjournals.schbul.a033461. PMID 10885639.
  11. ^ Bearden, Carrie E.; Wu, Keng Nei; Caplan, Rochelle; Cannon, Tyrone D. (July 4, 2011). "Thought disorder and communication deviance as predictors of outcome in youth at clinical high risk for psychosis". Journal of the American Academy of Child and Adolescent Psychiatry. 50 (7): 669–680. doi:10.1016/j.jaac.2011.03.021. PMC 3124656. PMID 21703494.
  12. ^ Do, Perkins; L, Olde Loohuis; J, Barbee; J, Ford; Cd, Jeffries; J, Addington; Ce, Bearden; Ks, Cadenhead; Td, Cannon; Ba, Cornblatt; Dh, Mathalon; Th, McGlashan; Lj, Seidman; M, Tsuang; Ef, Walker; Sw, Woods (February 1, 2020). "Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk". The American Journal of Psychiatry. 177 (2): 155–163. doi:10.1176/appi.ajp.2019.18060721. PMC 7202227. PMID 31711302.
  13. ^ Cao, Hengyi; Chén, Oliver Y.; Chung, Yoonho; Forsyth, Jennifer K.; McEwen, Sarah C.; Gee, Dylan G.; Bearden, Carrie E.; Addington, Jean; Goodyear, Bradley; Cadenhead, Kristin S.; Mirzakhanian, Heline; Cornblatt, Barbara A.; Carrión, Ricardo E.; Mathalon, Daniel H.; McGlashan, Thomas H.; Perkins, Diana O.; Belger, Aysenil; Seidman, Larry J.; Thermenos, Heidi; Tsuang, Ming T.; van Erp, Theo G. M.; Walker, Elaine F.; Hamann, Stephan; Anticevic, Alan; Woods, Scott W.; Cannon, Tyrone D. (September 21, 2018). "Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization". Nature Communications. 9 (1): 3836. Bibcode:2018NatCo...9.3836C. doi:10.1038/s41467-018-06350-7. PMC 6155100. PMID 30242220.
  14. ^ "Accelerating Medicines Partnership (AMP) Schizophrenia (SCZ) Principal Investigators". AMP SCZ.
  15. ^ "Samuel Gershon Junior Investigator Award".
  16. ^ "Grand Challenges | Team Member Spotlight Series: Carrie Bearden, PhD". November 15, 2023.
  17. ^ "Associate for Psychological Science Fellows".
  18. ^ "43 UCLA scholars among most highly cited researchers for 2021". UCLA.
  19. ^ "George M Thompson Award for Distinguished Service".
  20. ^ "UCLA Brain Research Institute (BRI)".
Retrieved from "https://en.wikipedia.org/w/index.php?title=Carrie_Bearden&oldid=1247078448"